XXVI Argentine and International Congress of Clinical Oncology organized by the AAOC

16/11/2023

November 8-10, the XXVI Argentine and International Congress of Clinical Oncology 2023 was held at the La Rural property, in the City of Buenos Aires.

Under the tagline “Cancer at the center of the community and science”, the congress featured the participation and presentations of national and international professionals, offering simultaneous sessions in the nine available rooms, which had an excellent attendance.

Our team participated with a large stand that allowed us to receive doctors, residents and patient associations from all over the country and deliver promotional literature about the laboratory and our Oncology Line products (especially our recent launches: Vetrano® palbociclib, Gombrich® cabacitaxel y Dalcara® sorafenib).

Once again, the synergy between Sales, Marketing and the Medical Department providing support was present.

Bioprofarma Bagó Announces In-Licensing Exclusive Partnership with Polaris Pharmaceuticals to introduce ADI-PEG20 (ADZODI®), an innovative First in class arginine degradation platform for hard-to-treat cancers in Argentina and other LATAM markets.

Buenos Aires, Argentina – Bioprofarma Bagó (a fully owned subsidiary of GRUPO EMPRESARIAL BAGO), today announced an exclusive licensing agreement with Polaris, a renowned American pharmaceutical company, to introduce ADI-PEG20 (ADZODI®), a novel treatment for Malignant Pleural Mesothelioma (MPM) to the LATAM. This partnership is set to improve the treatment landscape by delivering innovative therapeutic […]

New release LIPECELTE® trabectedin

Introducing LIPECELTE® Trabectedin: A New Addition to Our Oncology Line At Bioprofarma Bagó, we reaffirm our dedication to patient care with the launch of LIPECELTE® trabectedin, approved by ANMAT for the treatment of: – Advanced soft tissue sarcoma (STS) in adult patients who have failed anthracycline and ifosfamide treatment or are not candidates for these […]

(Español) Jornada de Uro Oncología FUCDIM

Sorry, this entry is only available in European Spanish.